Cancer Research UK logo.
SearchDonate
  • Search

A trial of selumetinib and docetaxel for non small cell lung cancer (SELECT-1)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Results

Phase:

Phase 3

Details

This trial was for people whose non small cell lung cancer had grown into surrounding tissues or spread elsewhere in the body. And whose lung cancer cells had a change () to a called KRAS.

Recruitment start: 30 October 2013

Recruitment end: 1 January 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Fiona Blackhall

Supported by

AstraZeneca

NIHR Clinical Research Network: Cancer

Last reviewed: 19 December 2017

CRUK internal database number: 11578

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.